Max Robotics — Global Service Robot Directory + US Certification

About

Emanuela Morenghi is a leading figure in thoracic surgery, renowned for advancing the application of robotic platforms in lung cancer treatment. Her research primarily focuses on the safety, efficacy, and optimization of robotic-assisted surgical techniques, particularly for complex and advanced-stage disease. A major contribution is her work on robotic resection for Stage III lung cancer, where her international retrospective study (75 citations) provided critical evidence supporting the feasibility of minimally invasive approaches for locally advanced tumors, challenging traditional surgical boundaries. Morenghi also pioneered preoperative risk assessment with the development of the "Pharyngoscore," a predictive tool for difficult oropharyngeal exposure in transoral robotic surgery (TORS), enhancing patient selection and procedural safety. Demonstrating a commitment to innovation in postoperative care, she led a prospective study on early hospital discharge (day two) after robotic lobectomy, integrating telehealth home monitoring to improve recovery and reduce hospital stays. With a growing citation impact and a focus on translating technology into better patient outcomes, Morenghi’s work is shaping the future of robotic thoracic surgery.